Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications

被引:49
作者
Ayad, F. [2 ]
Belhadj, M. [2 ]
Paries, J.
Attali, J. R.
Valensi, P. [1 ,3 ]
机构
[1] Univ Paris 13, Jean Verdier Hosp, AP HP,CRNH IdF, Serv Endocrinol Diabetol Nutr,Dept Endocrinol Dia, F-93140 Bondy, France
[2] Univ Hosp, Dept Internal Med, Oran, Algeria
[3] Univ Paris 13, Jean Verdier Hosp, AP HP, Dept Publ Hlth,CRNH IdF, F-93140 Bondy, France
关键词
cardiac autonomic neuropathy; diabetes; hypertension; macrovascular complications; microangiopathy; HEART-RATE-VARIABILITY; BLOOD-PRESSURE; IDDM PATIENTS; DISEASE; HUMANS; RISK; NEPHROPATHY; MECHANISMS; MORTALITY; DIAGNOSIS;
D O I
10.1111/j.1464-5491.2010.03027.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Aims To examine the association between cardiac autonomic neuropathy and hypertension and the role of this association in diabetic complications. Methods We included 310 patients, 138 with Type 1 and 172 with Type 2 diabetes, 62 of them with hypertension. Cardiac autonomic neuropathy was assessed by analysing heart rate variations during three standard tests (deep breathing, lying to standing and Valsalva) and looking for postural hypotension. Results Cardiac autonomic neuropathy was present in 123 patients and 39 also had hypertension. The prevalence of a cardiac autonomic neuropathy/hypertension association was higher in Type 2 patients (P < 0.002). The prevalence of hypertension increased with the severity of cardiac autonomic neuropathy. In multiple logistic regression analysis, cardiac autonomic neuropathy was an independent risk factor for hypertension [odds ratio 2.86 (1.54-5.32); P < 0.001]. Only confirmed or severe cardiac autonomic neuropathy (two or more abnormal function tests, respectively) were independent risk factors for hypertension (P < 0.005 and < 0.0001). Cardiac autonomic neuropathy was found in most of the patients with macrovascular complications, retinopathy or nephropathy, but a large majority of the patients with these complications exhibited the cardiac autonomic neuropathy/hypertension profile. This profile was more prevalent among the patients with coronary or peripheral artery disease or antecedent stroke than among those free of these complications (P < 0.001). In logistic regression analyses, the cardiac autonomic neuropathy/hypertension profile associated significantly with macro- and microvascular complications. Conclusions These data are strongly in favour of the role of cardiac autonomic neuropathy in hypertension in diabetic patients. The association of the cardiac autonomic neuropathy/hypertension profile with vascular complications is consistent with a deleterious effect on vascular hemodynamics and structure, additional to the effects of hypertension.
引用
收藏
页码:804 / 811
页数:8
相关论文
共 30 条
  • [1] EFFECT OF CORONARY-ARTERY DISEASE ON PARASYMPATHETIC CARDIOVASCULAR REFLEXES IN NIDDM PATIENTS
    AIRAKSINEN, KEJ
    KOISTINEN, MJ
    IKAHEIMO, MJ
    PIRTTIAHO, H
    HUIKURI, HV
    TAKKUNEN, JT
    [J]. DIABETES CARE, 1990, 13 (02) : 83 - 86
  • [2] ELEVATED SYMPATHETIC-NERVE ACTIVITY IN BORDERLINE HYPERTENSIVE HUMANS - EVIDENCE FROM DIRECT INTRANEURAL RECORDINGS
    ANDERSON, EA
    SINKEY, CA
    LAWTON, WJ
    MARK, AL
    [J]. HYPERTENSION, 1989, 14 (02) : 177 - 183
  • [3] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [4] Boulton AJM, 1998, DIABETIC MED, V15, P508, DOI 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO
  • [5] 2-L
  • [6] Brahimi M, 2001, ARCH MAL COEUR VAISS, V94, P944
  • [7] AUTONOMIC NEUROPATHY, QT INTERVAL LENGTHENING, AND UNEXPECTED DEATHS IN MALE DIABETIC-PATIENTS
    EWING, DJ
    BOLAND, O
    NEILSON, JMM
    CHO, CG
    CLARKE, BF
    [J]. DIABETOLOGIA, 1991, 34 (03) : 182 - 185
  • [8] Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease - The Hoorn study
    Gerritsen, J
    Dekker, JM
    TenVoorde, BJ
    Kostense, PJ
    Heine, RJ
    Bouter, LM
    Heethaar, RM
    [J]. DIABETES CARE, 2001, 24 (10) : 1793 - 1798
  • [9] Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment
    Giannattasio, C
    Mancia, G
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (10) : 1889 - 1899
  • [10] Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans
    Grassi, G
    Seravalle, G
    Colombo, M
    Bolla, G
    Cattaneo, BM
    Cavagnini, F
    Mancia, G
    [J]. CIRCULATION, 1998, 97 (20) : 2037 - 2042